Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: An intergroup rhabdomyosarcoma study
Ja. Bridge et al., Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: An intergroup rhabdomyosarcoma study, GENE CHROM, 27(4), 2000, pp. 337-344
A comparative genomic hybridization (CGH) approach provides identification
of genomic gains and losses in a tumor specimen in a single experiment. Onl
y II embryonal rhabdomyosarcomas (E-RMS) have previously been subjected to
CGH. The underlying genetic events in this histologic subtype are not well
defined. In this investigation, 12 E-RMS specimens from 10 patients entered
into Intergroup Rhabdomyosarcoma Study (IRS) I-IV and two local patients:w
ere analyzed by CGH and fluorescence in situ hybridization (FISH). Gains of
chromosomes or chromosomal regions 2 (50%), 7 (42%), 8 (67%), 11 (42%), 12
(58%), 13q21 (33%), and 20 (33%) and losses of 1p35-36.3 (42%), 6 (33%), 9
q22 (33%), 14q21-32 (25%), and 17 (25%) were most prominent. Chromosomal re
gions 1p35-36.3 and 9q22 represent novel regions of loss. Importantly, loss
of 9q22 corresponds to the locus of a putative tumor suppressor gene (PTCH
), which has been shown to play a role in rhabdomyosarcoma in a mouse model
of Gorlin syndrome. Loss of 1p36 corresponds to the locus for PAX7, a pair
ed box containing gene characteristically altered in alveolar rhabdomyosarc
oma. Moreover, loss of 1p36 is prominent In another common pediatric soft t
issue tumor, neuroblastoma. Gains of 2, 7, 8, 12, and 13 and loss of 14 wer
e seen in the sole prior E-RMS CGH series; thus, these data provide importa
nt confirmatory results. In contrast to this previous study, however loss,
not gain, of chromosome 17 was observed in the current study. Chromosome 17
loss correlates well with previous descriptions of frequent allelic loss o
f 17p (TP53) in E-RMS. In summary, CGH and FISH analyses of 12 E-RMS specim
ens revealed novel genomic imbalances that may be useful in directing furth
er molecular studies for the determination of E-RMS critically involved gen
es. (C) 2000 Wiley-Liss, Inc.